Jeff Gladd, MD, CHAIRMAN Susan Blum, MD Tom O'Bryan, DC Shayma Kazmi, MD, RPh Mark Tager, MD James Maskell Derrick DeSilva, Jr, MD Jacques Simon, Esq Sarath Malepati, MD Ron Hoffman, MD Joel Evans, MD Anita Teresa Boeninger, RYT Melissa Crispell Joseph Hickey, MD Mette Dyhrberg Thomas Blomseth Christiansen Lillie Rosenthal, DO Mark Menolascino, MD Georgia Tetlow, MD Aimon Kopera, MD & Peter Evans, PhD
Erik Goldman Jeff Gladd, MD Shilpa Saxena, MD Michael Gaeta, Lac Chad Larson, NMD, DC Steven Masley, MD David Perlmutter, MD Marcela Dominguez, MD Erin Martin, DO Richard Jaffe, Esq. Deanna Minich, PhD Harry Massey Miriam Zacharias James Maskell John La Puma, MD Tina Beaudoin, ND Mette Dyhrberg & Thomas Blomseth Christiansen
Incidence of Celiac, Gluten Intolerance On the Rise, says Mayo Study
Wednesday, 31 October 2012 14:19
By John Otrompke, Contributing Writer
Approximately 1% of American Caucasians may now have celiac disease, according to a major epidemiologic survey by researchers at the Mayo Clinic.
Once thought to be rare and largely marginalized by mainstream medicine, conditions like celiac disease and gluten intolerance are proving to be much more common—and serious—than previously thought.
“It’s kind of ironic: we estimate that 1.8 million Americans have celiac disease, but most don’t know, and they’re not on treatment although they should be,” explained Dr. Joseph Murray, MD, professor of medicine, and a consultant in gastroenterology and immunology at the Mayo Clinic, in Rochester, Minnesota.
“On the other hand, 1.6 million are on the gluten-free diet, and most don’t have a diagnosis, so we don’t know if they need to be on the diet,” added Dr. Murray, one of the co-authors of the study, published earlier this fall inAmerican Journal of Gastroenterology.
Celiac disease is a condition that affects the small intestine, and is the result of an immune reaction to gluten. The gut gets inflamed, and the individual may get diarrhea, bloating, or weight loss. “But celiac can also affect the skin, the nervous system, hormones, the lungs, or virtually any part of the body,” Dr. Murray said.
Until fairly recently, conventional medical wisdom held that celiac disease was extremely rare, and physicians often dismissed patient complaints as “psychosomatic.” Clearly, things have changed.
Four-Fold Higher Mortality
In the Mayo Clinic study, researchers examined blood samples from 7,798 participants, aged 6 years and older, in the National Health and Nutrition Examination Survey (NHANES) for 2009 and 2010. Participants were also asked two questions: whether they were on a gluten-free diet, and whether they had been given a diagnosis of celiac disease by a health care professional.
Of the 7,798 participants, 34 (0.4%) had definitively positive blood tests for celiac, or 34 patients, and another 15 (0.2%) were weakly positive in 0.2%. Median age of the patients was 38, and half were female, 44% were non-Hispanic white, 32% were Hispanic, and 18% were non-Hispanic black. On the basis of 35 cases that were either serologically diagnosed with celiac disease or a reported clinical diagnosis, the prevalence of celiac disease in the U.S. was 0.71%, but among non-Hispanic whites, the prevalence was 1.1%, according to the article.
In an earlier study, Murray and colleagues examined stored blood samples from 9,133 young male recruits between 1948 and 1954 from an Air Force base in Wyoming, and tested them for markers for celiac disease. In addition, they gathered 45-year follow-up data for those with and without markers for celiac disease, and compared all-cause mortality for the two groups, according to the article, ‘Increased Prevalence and Mortality in Undiagnosed Celiac Disease,’which was published in the July 2009 issue of Gastroenterology.
The Mayo team determined that of the cohort, 0.2% (or 14 participants) had undiagnosed celiac disease.
Rising Prevalence in Elders
On follow-up, those with undiagnosed celiac disease were 3.9 times more likely to have died of any cause than those who did not have the condition. Additionally, during the 2009 study, researchers examined a contemporary sample of persons with a similar age and found undiagnosed celiac disease in 0.9% of that cohort, or 4.5 times as many participants as in the 1964 study.
“We’re also seeing celiac start for the first time in the elderly,” said Dr. Murray, though he hesitated to give reasons for this phenomenon.
“Maybe it’s something about contemporary food preparation, or something about hygiene,” he said. Alternatively, researchers have speculated that the rise could be attributed to greater consumption of processed wheat products like pastas and baked goods than in decades past, or it could be due to new forms of wheat, which were cross-bred by scientists in the 1950s to make hardier, shorter and better-growing plants.
Whatever the cause, the results called for greater surveillance. “We’re obviously not doing a great job from the medical perspective,” said Dr. Murray. He suggested that patients should get tested for celiac disease before switching to a gluten-free diet, “Going on the diet may delay diagnosis, and may lead to slowed growth in children.”
He advised caution with genetic tests, suggesting that they should only be used under a physician’s direction, because approximately 30% of the population has the genes for celiac disease, but most people never develop symptoms.
Predictive antibody testing puts state of the art immunologic tools in the hands of practicing clinicians, enabling early detection of triggers & predisposing factors for many disorders---long before they become chronic and debilitating!
In this online course, you'll earn 6 AMA Category 1 credits as you learn how predictive antibody testing can revolutionize your care for patients with:
Gastrointesteinal + Liver
Thyroid, Adrenal, Reproductive Organs
Bone and Joint Disorders
Faculty: Aristo Vojdani, PhD; Thomas Alexander, MD; Chad Larson, DC, NMD